Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

Completed · Phase 4

Conditions studied: Uveitis

In brief

The purpose of this study is to collect data on patients with severe uveitis that have required re-implantation of the sustained-release fluocinolone drug delivery device due to depletion of study drug in their previous implanted device.

Key facts

Study ID

NCT00543296

Run by

Duke University

People needed

21

Starts

2004-03-01

Expected to finish

2007-07-01

Last updated by the study team

2015-03-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Non-infectious intermediate, posterior or panuveitis
• Previous placement of fluocinolone acetonide implant with initial uveitis quiescence and subsequent recurrence of inflammation once implant depleted of drug

You may not qualify if…

• Infectious uveitis

Where it is running

• Duke University Eye Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.